Zobrazeno 1 - 10
of 2 302
pro vyhledávání: '"Callard, R."'
Autor:
Payne, H, Chain, G, Adams, S, Hunter, P, Luckhurst, N, Gilmour, K, Lewis, J, Babiker, A, Cotton, M, Violari, A, Gibb, D, Callard, R, Klein, N
In this study, we aimed to quantify KREC (kappa-deleting recombination excision circle) levels and naive B cell output in healthy HIV-uninfected children, compared with HIV-infected South African children, before and after starting ART (antiretrovira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::8a42cdcc312b060fb9b2b5a53a7c8194
http://hdl.handle.net/10044/1/99334
http://hdl.handle.net/10044/1/99334
Autor:
Callard, R. E.1, Smith, Caroline M.1, Worman, C.2, Linch, D.2, Cawley, J. C.2, Beverley, P. C. L.1
Publikováno v:
Clinical & Experimental Immunology. Mar1981, Vol. 43 Issue 3, p497-505. 9p.
Autor:
Kerr, F, Sofola-Adesakin, O, Ivanov, DK, Gatliff, J, Perez-Nievas, BG, Bertrand, HC, Martinez, P, Callard, R, Snoeren, I, Cocheme, HM, Adcott, J, Khericha, M, Castillo-Quan, JI, Wells, G, Noble, W, Thornton, J, Partridge, L
Publikováno v:
PLoS Genet
PLoS Genetics, Vol 13, Iss 3, p e1006593 (2017)
PLoS Genetics, Vol 13, Iss 3, p e1006593 (2017)
Nrf2, a transcriptional activator of cell protection genes, is an attractive therapeutic target for the prevention of neurodegenerative diseases, including Alzheimer's disease (AD). Current Nrf2 activators, however, may exert toxicity and pathway ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0c754041ac487a896d47d0842e2d4784
https://hdl.handle.net/21.11116/0000-000B-4F6A-7
https://hdl.handle.net/21.11116/0000-000B-4F6A-7
Publikováno v:
Clinical & Experimental Allergy. Mar2004, Vol. 34 Issue 3, p445-449. 5p.
Autor:
Uronen, H.1, Callard, R. E.1
Publikováno v:
Clinical & Experimental Immunology. Aug2000, Vol. 121 Issue 2, p346-352. 7p.
The monoclonal antibody UCHL1 identified an antigen present on most thymocytes, a subpopulation of resting T cells within both the CD4 and CD8 subsets, and on mature activated T cells. The UCHL1 determinant is also present on cells of the myeloid lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e20c1dad84b5501ca6741c827eabc1c4
https://ora.ox.ac.uk/objects/uuid:a8e4fc7c-b074-4c5c-86b4-cc32ec70eeee
https://ora.ox.ac.uk/objects/uuid:a8e4fc7c-b074-4c5c-86b4-cc32ec70eeee
Autor:
Shaw, L, Harjunmaa, U, Doyle, R, Mulewa, S, Charlie, D, Maleta, K, Callard, R, Walker, A, Balloux, F, Ashorn, P, Klein, N
Publikováno v:
Applied and Enviromental Microbiology. 82(19)
UNLABELLED: Periodontal disease ranges from gingival inflammation (gingivitis) to the inflammation and loss of tooth-supporting tissues (periodontitis). Previous research has focused mainly on subgingival plaque, but supragingival plaque composition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1acd025085df2a48d0dbf2b55f2985aa
http://ora.ox.ac.uk/objects/uuid:479be1c5-fc80-43be-bb11-081efd952d42
http://ora.ox.ac.uk/objects/uuid:479be1c5-fc80-43be-bb11-081efd952d42
Publikováno v:
Clinical Pharmacology & Therapeutics; Aug2017, Vol. 102 Issue 2, p349-357, 9p
Autor:
Genevier, H. C.1, Callard, R. E.1
Publikováno v:
Clinical & Experimental Immunology. Dec1997, Vol. 110 Issue 3, p386-391. 6p.
Publikováno v:
Clinical & Experimental Immunology. Oct1984, Vol. 58 Issue 1, p136-144. 9p.